BioWorld - Tuesday, January 28, 2020

Digital health
%{topic} RSS Feed RSS

1-28-Biointellisense-Biosticker.png

Biointellisense scores win at FDA with the clearance of its Biosticker

January 28, 2020
By Liz Hollis
No Comments
Biointellisense Inc. received good news from the U.S. FDA, which gave its nod to the company’s Biosticker on-body sensor for scalable remote care. The Biosticker allows for continuous monitoring of vital signs and actionable insights, delivered to clinicians from patients in the home setting. The goal is to help in the early detection of potentially avoidable complications.
Read More
business-performance-pipeline.png
Precision Medicine World Conference

Amazon’s Majmudar discusses challenges of getting novel tech to market

January 24, 2020
By Holland Johnson
No Comments
SANTA CLARA, Calif. – Translating novel technology into the care delivery system is not easy, according to Maulik Majmudar, medical officer at Bellevue, Wash.-based Amazon.com Inc. In fact, he said at the Precision Medicine World Conference that “it’s a hot mess.” In his presentation, Majmudar spoke about the classic barriers that prevent technologies from getting adopted at scale in a timeline that's usually feasible for early- and mid-stage startups – and even for large companies – and developing strategies to overcome those challenges.
Read More
Puzzle-pieces-globe.png
Precision Medicine World Conference

Verily highlights diabetes care, Project Baseline even as related partnerships are restructured

January 24, 2020
By Stacy Lawrence
No Comments
SANTA CLARA, Calif. – Diabetes seems likely to be the first area to really show concrete products and results for the ambitious Verily Life Sciences, which is the med-tech business of Mountain View, Calif.-based Google parent Alphabet Inc. However, its two major diabetes partners both have been rethinking the relationship.
Read More
Gene therapy
Precision Medicine World Conference

AI, data science companies strut their stuff at PMWC

January 23, 2020
By Holland Johnson
No Comments
SANTA CLARA, Calif. – While many of the presentations at the Precision Medicine World Conference revolved around clinical studies and their promise for future breakthroughs in health care, a continuous stream of companies made their pitches for translating these studies into actual products that can benefit patients now.
Read More
AI_landscape.png

French university hospitals grasp AI

January 21, 2020
By Bernard Banga
No Comments
PARIS – EY SAS has published the results of the first edition of a barometer dedicated to the role of artificial intelligence (AI) in French public hospitals. The health care sector, which is undergoing wholesale change in France, is suffering tight economic constraints and faces ever-increasing expectations from patients. “The development of [AI] in France is a priority. It's a matter of gauging it,” Loïc Chabanier, an EY partner responsible for health care, told BioWorld.
Read More
3D-head-brain-cancer

Novel imaging, AI combo enables rapid, accurate brain tumor diagnosis during surgery

January 21, 2020
By Stacy Lawrence
No Comments
Unlike with other kinds of cancer, there’s no opportunity for a biopsy ahead of surgery for a suspected brain tumor. To help matters, researchers have developed a novel approach that combines a new, commercially available imaging technology – stimulated Raman histology (SRH) – with an artificial intelligence (AI) algorithm to offer a diagnosis of brain tumors in just a couple of minutes. They published the results of a study in the Jan. 6, 2020, issue of Nature Medicine that determined their approach was noninferior to standard pathologist interpretation of histologic images.
Read More

Olive Healthcare attracts $6.91M in series B funding

January 15, 2020
By Jihyun Kim
No Comments
HONG KONG – South Korean med tech Olive Healthcare Inc. has attracted ₩8 billion (US$6.91 million) in series B funding. The Seoul-based company is focused on abdominal fat scanning and breast cancer diagnosis, using nonradiative and noninvasive near infrared (NIR) technology, artificial intelligence (AI) algorithms, and big data processing for a customized medical service.
Read More
1-15-insulet-omnipod-dash.png
J.P. Morgan Healthcare Conference

Insulet to launch wearable insulin pump this year, works with Dexcom iCGM for closed loop

January 15, 2020
By Stacy Lawrence
No Comments
SAN FRANCISCO – Insulet Corp. aims to get an FDA approval this year and launch its first interoperable device, the cord-free, wearable insulin device Omnipod Horizon. It is designed to be compatible with the Dexcom G6 and is the result of a partnership between the two companies. In combination, the devices will operate as a closed loop system to automatically adjust insulin dosage over time in response to blood glucose levels.
Read More
Deal-handshake-wire-frame.png

Masimo to buy Nanthealth’s connected care business, provides estimates for 2020 guidance

January 14, 2020
By Liz Hollis
No Comments
Irvine, Calif.-based Masimo Corp. has agreed to buy the connected care assets of Nanthealth Inc., of Culver City, Calif., for a $47.25 million up-front cash payment. In addition, Masimo provided estimates for its full-year 2020 financial guidance, saying product revenue will increase to $1.035 billion, which reflects reported growth of 10.6% to 10.9%. The transaction is expected to close in the first quarter of the year, subject to customary closing conditions. In addition, Masimo expects to fund the acquisition with existing cash on hand.
Read More

Popular Stories

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Subscribe